Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
Anti-Inflammatory Agents
/ therapeutic use
Antigens, Differentiation
/ genetics
Antiviral Agents
/ therapeutic use
Betacoronavirus
/ drug effects
COVID-19
Complement System Proteins
/ genetics
Coronavirus Infections
/ drug therapy
Data Mining
/ methods
Databases, Genetic
Gene Expression Regulation
HIV Infections
/ drug therapy
HIV-1
/ drug effects
Host-Pathogen Interactions
/ drug effects
Humans
Immunity, Innate
/ drug effects
Immunologic Factors
/ therapeutic use
Inflammation
Interferons
/ genetics
Interleukins
/ genetics
Metabolic Networks and Pathways
/ drug effects
Pandemics
Pneumonia, Viral
/ drug therapy
Repressor Proteins
/ genetics
SARS-CoV-2
Signal Transduction
Toll-Like Receptors
/ genetics
Ubiquitin-Protein Ligases
/ genetics
HIV-1
SARS
SARS-CoV-2
data mining
text mining
virus–host interactions
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
26 Jun 2020
26 Jun 2020
Historique:
received:
04
05
2020
revised:
22
06
2020
accepted:
24
06
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
7
7
2020
Statut:
epublish
Résumé
Viruses can be spread from one person to another; therefore, they may cause disorders in many people, sometimes leading to epidemics and even pandemics. New, previously unstudied viruses and some specific mutant or recombinant variants of known viruses constantly appear. An example is a variant of coronaviruses (CoV) causing severe acute respiratory syndrome (SARS), named SARS-CoV-2. Some antiviral drugs, such as remdesivir as well as antiretroviral drugs including darunavir, lopinavir, and ritonavir are suggested to be effective in treating disorders caused by SARS-CoV-2. There are data on the utilization of antiretroviral drugs against SARS-CoV-2. Since there are many studies aimed at the identification of the molecular mechanisms of human immunodeficiency virus type 1 (HIV-1) infection and the development of novel therapeutic approaches against HIV-1, we used HIV-1 for our case study to identify possible molecular pathways shared by SARS-CoV-2 and HIV-1. We applied a text and data mining workflow and identified a list of 46 targets, which can be essential for the development of infections caused by SARS-CoV-2 and HIV-1. We show that SARS-CoV-2 and HIV-1 share some molecular pathways involved in inflammation, immune response, cell cycle regulation.
Identifiants
pubmed: 32604797
pii: molecules25122944
doi: 10.3390/molecules25122944
pmc: PMC7357070
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Antigens, Differentiation
0
Antiviral Agents
0
Immunologic Factors
0
Interleukins
0
Repressor Proteins
0
Toll-Like Receptors
0
leu-13 antigen
0
Complement System Proteins
9007-36-7
Interferons
9008-11-1
ITCH protein, human
EC 2.3.2.26
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Science Foundation
ID : 19-75-10097
Références
Cell Mol Immunol. 2020 Apr 7;:
pubmed: 32265513
PLoS One. 2012;7(3):e34240
pubmed: 22479575
Arch Med Res. 2020 Apr 29;:
pubmed: 32387040
mBio. 2018 Oct 9;9(5):
pubmed: 30301856
Nat Commun. 2019 Jul 2;10(1):2753
pubmed: 31266936
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Molecules. 2020 May 17;25(10):
pubmed: 32429580
Pharmacol Ther. 2020 May 26;:107587
pubmed: 32470470
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Clin Immunol. 2020 Jun;215:108450
pubmed: 32360516
Int J Antimicrob Agents. 2020 Apr 17;:105984
pubmed: 32305589
Cell Host Microbe. 2020 May 13;27(5):699-703
pubmed: 32407708
J Virol. 2018 Nov 12;92(23):
pubmed: 30232188
Life Sci. 2020 Aug 1;254:117765
pubmed: 32437797
J Infect Dis. 2015 Aug 1;212(3):474-83
pubmed: 25657259
Korean J Intern Med. 2020 Jun 16;:
pubmed: 32536150
BMC Med. 2020 Mar 25;18(1):81
pubmed: 32209092
Sci Transl Med. 2018 May 2;10(439):
pubmed: 29720451
Semin Cancer Biol. 2020 Mar 10;:
pubmed: 32165318
J Public Health Res. 2020 Jun 04;9(1):1786
pubmed: 32550223
Curr Top Med Chem. 2016;16(10):1167-90
pubmed: 26324041
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Sci Rep. 2019 May 29;9(1):8006
pubmed: 31142756
J Virol. 2017 Mar 29;91(8):
pubmed: 28148787
Immun Ageing. 2014 Mar 19;11(1):4
pubmed: 24642138
J Neuroinflammation. 2017 Jan 26;14(1):23
pubmed: 28122624
Emerg Microbes Infect. 2020 Dec;9(1):378-381
pubmed: 32056509
J Biol Chem. 2012 Nov 30;287(49):41481-98
pubmed: 23071112
Ann Transl Med. 2020 Mar;8(5):244
pubmed: 32309391
Arch Virol. 2020 Aug;165(8):1729-1737
pubmed: 32514689
Mol Ther Nucleic Acids. 2020 Jun 5;20:606-620
pubmed: 32348938
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
AIDS. 2013 Jan 28;27(3):347-56
pubmed: 23291538
Curr Top Microbiol Immunol. 2017;407:31-63
pubmed: 28653187
J Exp Clin Cancer Res. 2020 May 12;39(1):86
pubmed: 32398164
Nat Commun. 2019 Dec 18;10(1):5770
pubmed: 31852899
Infect Dis Clin North Am. 2020 Jun;34(2):211-234
pubmed: 32334983
Infect Genet Evol. 2013 Dec;20:78-82
pubmed: 23962581
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
J Chem Inf Model. 2018 Feb 26;58(2):212-218
pubmed: 29300482
J Virol. 2017 Apr 13;91(9):
pubmed: 28202764
J Clin Invest. 2020 May 1;130(5):2202-2205
pubmed: 32217834
J Biomol Struct Dyn. 2020 Apr 20;:1-14
pubmed: 32266873
Nat Biotechnol. 2010 Aug;28(8):839-47
pubmed: 20601939
Curr HIV Res. 2014;12(2):111-20
pubmed: 24862331
J Int AIDS Soc. 2020 Apr;23(4):e25489
pubmed: 32293807
Microb Cell. 2020 May 04;7(5):119-128
pubmed: 32391393
Clin Rheumatol. 2020 Jul;39(7):2085-2094
pubmed: 32474885
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841
pubmed: 22229120
PLoS One. 2011 Apr 25;6(4):e19352
pubmed: 21541353
Biochim Biophys Acta. 2014 Aug;1840(8):2571-80
pubmed: 24631662
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):407-412
pubmed: 32335367
Protein Cell. 2014 Dec;5(12):912-27
pubmed: 25311841
Front Microbiol. 2018 Dec 17;9:2940
pubmed: 30619107
Nucleic Acids Res. 2020 Jan 8;48(D1):D845-D855
pubmed: 31680165
Cell Mol Immunol. 2010 Sep;7(5):334-40
pubmed: 20228834
J Chemother. 2020 Jun 12;:1-5
pubmed: 32530369
Pharmacol Res. 2020 Jul;157:104859
pubmed: 32360480
J Immunol. 2012 Jan 15;188(2):818-23
pubmed: 22174453
Front Immunol. 2020 May 28;11:1229
pubmed: 32574272
Science. 2020 May 22;368(6493):829-830
pubmed: 32385101
J Chem Inf Model. 2019 Sep 23;59(9):3635-3644
pubmed: 31453694
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Biochem Biophys Res Commun. 2020 Jun 30;527(3):618-623
pubmed: 32416961
Bioinformatics. 2003;19 Suppl 1:i180-2
pubmed: 12855455
J Autoimmun. 2020 Jul;111:102468
pubmed: 32317220
J Neuroimmune Pharmacol. 2018 Sep;13(3):355-370
pubmed: 29752681
Cell Stem Cell. 2014 Nov 6;15(5):643-52
pubmed: 25517468
J Clin Invest. 2018 Oct 1;128(10):4387-4396
pubmed: 30148455
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
J Gen Virol. 2017 Apr;98(4):821-834
pubmed: 28141491
Autoimmun Rev. 2017 Oct;16(10):1049-1057
pubmed: 28778707
Front Med. 2020 Apr;14(2):117-125
pubmed: 32318975
Brief Bioinform. 2011 Sep;12(5):449-62
pubmed: 21873635
Curr Res Transl Med. 2020 May 30;:
pubmed: 32540367